Search Results - "Oostenbrink, Jan B"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? by Rutten-van Mölken, Maureen P M H, Oostenbrink, Jan B, Tashkin, Donald P, Burkhart, Deborah, Monz, Brigitta U

    Published in Chest (01-10-2006)
    “…To assess the discriminative properties of the EuroQol five-dimension questionnaire (EQ-5D) with respect to COPD severity according to Global Initiative for…”
    Get more information
    Journal Article
  2. 2

    Resource use and risk factors in high-cost exacerbations of COPD by Oostenbrink, Jan B, Rutten-van Mölken, Maureen P.M.H

    Published in Respiratory medicine (01-09-2004)
    “…Patients hospitalised for exacerbations contribute significantly to the total chronic obstructive pulmonary disease (COPD)-related healthcare costs. This study…”
    Get full text
    Journal Article
  3. 3

    Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research by Oostenbrink, Jan B., PhD, Al, Maiwenn J., PhD, Oppe, Mark, MSc, Rutten-van Mölken, Maureen P.M.H., PhD

    Published in Value in health (01-12-2008)
    “…Abstract Objective Value of information (VOI) analysis informs decision-makers about the expected value of conducting more research to support a decision. This…”
    Get full text
    Journal Article
  4. 4

    The analysis of incomplete cost data due to dropout by Oostenbrink, Jan B., Al, Maiwenn J.

    Published in Health economics (01-08-2005)
    “…Incomplete data due to premature withdrawal (dropout) constitute a serious problem in prospective economic evaluations that has received only little attention…”
    Get full text
    Journal Article
  5. 5

    Standardisation of costs: the Dutch Manual for Costing in economic evaluations by Oostenbrink, Jan B, Koopmanschap, Marc A, Rutten, Frans F H

    Published in PharmacoEconomics (2002)
    “…The lack of a uniform costing methodology is often considered a weakness of economic evaluations that hinders the interpretation and comparison of studies…”
    Get full text
    Journal Article
  6. 6

    The risk of upcoding in casemix systems: A comparative study by Steinbusch, Paul J.M, Oostenbrink, Jan B, Zuurbier, Joost J, Schaepkens, Frans J.M

    Published in Health policy (Amsterdam) (01-05-2007)
    “…Abstract With the introduction of a diagnosis related group (DRG) classification system in the Netherlands in 2005 it has become relevant to investigate the…”
    Get full text
    Journal Article
  7. 7

    Probabilistic Markov Model to Assess the Cost-Effectiveness of Bronchodilator Therapy in COPD Patients in Different Countries by Oostenbrink, Jan B., Rutten-van Mölken, Maureen P.M.H., Monz, Brigitta U., FitzGerald, J. Mark

    Published in Value in health (2005)
    “…The development of a probabilistic Markov model with a time horizon of 1 year to compare the cost-effectiveness of three bronchodilators: 1) the new…”
    Get full text
    Journal Article
  8. 8

    Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain by H., Maureen P. M., Mölken, Rutten-van, Oostenbrink, Jan B., Miravitlles, Marc, Monz, Brigitta U.

    Published in The European journal of health economics (01-06-2007)
    “…Our objective was to assess the 5-year cost effectiveness of bronchodilator therapy with tiotropium, salmeterol or ipratropium for chronic obstructive…”
    Get full text
    Journal Article
  9. 9

    Unit Costs of inpatient hospital days by OOSTENBRINK, Jan B, BUIJS-VAN DER WOUDE, Tineke, VAN AGTHOVEN, Michel, KOOPMANSCHAP, Marc A, RUTTEN, Frans F. H

    Published in PharmacoEconomics (2003)
    “…Costs of inpatient days in hospitals are frequently the main drivers of total treatment costs, and their unit cost can markedly affect the outcomes of an…”
    Get full text
    Journal Article
  10. 10

    A comparative study of resource use and costs of renal, liver and heart transplantation by Oostenbrink, Jan B, Kok, Esther T, Verheul, Renate M

    Published in Transplant international (01-04-2005)
    “…Organ transplantations are among the most expensive surgical treatments performed today, but estimates of the costs of organ transplantations vary widely…”
    Get more information
    Journal Article
  11. 11

    Methods to analyse cost data of patients who withdraw in a clinical trial setting by OOSTENBRINK, Jan B, AL, Maiwenn J, H. RUTTEN-VAN MOLKEN, Maureen P. M

    Published in PharmacoEconomics (01-01-2003)
    “…Missing data resulting from premature study withdrawal are a common problem in the analysis of longitudinal data in clinical trials. To date, this subject has…”
    Get full text
    Journal Article
  12. 12

    Resource Use and Costs of Patients With Glaucoma or Ocular Hypertension: A One-year Study Based on Retrospective Chart Review in the Netherlands by Oostenbrink, Jan B, Rutten-van Mölken, Maureen P. M. H, Sluyter-Opdenoordt, Tanya S

    Published in Journal of glaucoma (01-06-2001)
    “…PURPOSETo estimate resource use and costs associated with the diagnosis and treatment of glaucoma and ocular hypertension in the Netherlands in 1996 and to…”
    Get full text
    Journal Article
  13. 13

    Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery by Oostenbrink, Jan B., Tangelder, Marco J.D., Busschbach, Jan J.V., van Hout, Ben A., Buskens, Erik, Algra, Ale, Lawson, James A., Eikelboom, Bert C.

    Published in Journal of vascular surgery (01-08-2001)
    “…Purpose: Several antithrombotic therapies are available for the treatment of patients with peripheral vascular diseases. It is unknown how quality of life and…”
    Get full text
    Journal Article
  14. 14

    Cost-utility analysis of patient care in children with meningeal signs by Oostenbrink, Rianne, Oostenbrink, Jan B, Moons, Karel G M, Derksen-Lubsen, Gerarda, Essink-Bot, Marie-Louise, Grobbee, Diederick E, Redekop, W Ken, Moll, Henriëtte A

    “…We designed a model of diagnostic and therapeutic interventions applied in children with meningeal signs. Using this model, we determined in a cost-utility…”
    Get more information
    Journal Article
  15. 15

    Application of a diagnostic decision rule in children with meningeal signs: a cost-minimization study by Oostenbrink, Rianne, Oostenbrink, Jan B, Moons, Karel G M, Derksen-Lubsen, Gerarda, Grobbee, Diederick E, Redekop, W Ken, Moll, Henriëtte A

    “…Recently, we developed a diagnostic rule for the diagnosis and treatment of children with meningeal signs. This rule may provide the physician with a rationale…”
    Get more information
    Journal Article